Methodist Health System COVID-19 Patient Registry

This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Clinical Research Institute Methodist Health System

Dallas, Texas, 75203, United States

About this study

This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19. Data including, but not limited to demographics, comorbidities, medications, treatment, and clinical outcomes will be collected from February 2020 to December 2025. Subjects will undergo no additional tests or procedures as part of this registry study. All patient data will be obtained from the patient's electronic health records (EHR) of the hospital or clinic in a retrospective manner. The process for gathering the data will not influence treatment decisions. There will be no direct patient contact associated with inclusion in this registry study.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient tested positive for COVID-19 (SARS-CoV-2)
Patient sought care for COVID-19 at a MHS facility
Aged 18 years or older

Exclusion criteria

Patient that do not have COVID-19
Non-confirmed COVID-19 patients
Aged 17 years or younger

Treatment and study plan

Treatment for COVID-19

Other

Patients treated for COVID-19

Primary outcomes

Patient Characteristics

Time frame: June 2020 - Dec 2025

Patient characteristics
Treatment Measures and Intervention strategies

Time frame: June 2020 - Dec 2025

Treatment measures and intervention strategies
Clinical and survival outcomes

Time frame: June 2020 - Dec 2025

Clinical and survival outcomes

Sponsors and collaborators

Lead sponsor

Methodist Health System

Other

Registry information

Important dates

Study start: 2020
Primary completion: 2025
Study completion: 2025
First posted: Jul 20, 2020
Registry last updated: May 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed